Mark For: ENTADFI® trademark registration is intended to cover the category of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 90830745 |
Registration Number | 6981815 |
Mark Literal Elements | ENTADFI |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK |
Register | PRINCIPAL |
Current Location | TMO LAW OFFICE 301 2022-10-01 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Bruce S. Londa |
Attorney Docket Number | 119595-61 |
2021-07-15 | Application Filed |
2021-07-19 | Location: NEW APPLICATION PROCESSING |
2021-07-19 | Status: Live/Pending |
2021-07-19 | Transaction Date |
2022-05-03 | Published |
2022-08-24 | Date of First Use |
2022-08-24 | Date of Use In Commerce |
2022-10-01 | Location: TMO LAW OFFICE 301 |
2022-10-01 | Status: A Statement of Use has been forwarded to the examining attorney for examination. |
Party: | ![]() |
Address | 201 E. FIFTH STREET SUITE 1900 CINCINNATI, OHIO UNITED STATES 45202 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
Party: | ![]() |
Address | Suite 1000 2916 North Miami Ave. Miami, FLORIDA UNITED STATES 33127 |
Legal Entity Type | Corporation |
Legal Entity State | WISCONSIN |
![]() | 2021-07-15 | |
![]() | 2021-07-15 | |
![]() | 2022-03-25 | |
![]() | 2022-03-26 | |
![]() | 2022-04-13 | |
![]() | 2022-04-13 | |
![]() | 2022-05-03 | |
![]() | 2022-05-13 | |
![]() | 2022-06-28 | |
![]() | 2022-09-20 | |
![]() | 2022-09-20 | |
![]() | 2022-10-04 | |
![]() | 2022-11-01 | |
![]() | 2022-11-01 | |
![]() | 2022-11-01 | |
![]() | 2022-12-29 | |
![]() | 2023-01-10 | |
![]() | 2023-01-10 | |
![]() | 2023-02-14 | |
![]() | 2023-02-14 |
IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceutical product for treatment of symptoms of an enlarged prostate and for improving urinary flow. FIRST USE: 20220824. FIRST USE IN COMMERCE: 20220824
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical product for treatment of symptoms of an enlarged prostate and for improving urinary flow |
GS0051 | Pharmaceutical product for treatment of symptoms of an enlarged prostate and for improving urinary flow |
Description | Date |
---|---|
![]() | 2023-04-27 |
Description | Date | Proceeding Number |
---|---|---|
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2023-05-03 | |
REGISTERED-PRINCIPAL REGISTER | 2023-02-14 | |
NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2023-02-14 | |
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2023-01-10 | |
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2023-01-09 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-12-28 | 96463 |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-12-28 | 96463 |
ASSIGNED TO LIE | 2022-12-27 | 96463 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-11-01 | |
SU - NON-FINAL ACTION - WRITTEN | 2022-11-01 | 96807 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2022-11-01 | |
NON-FINAL ACTION E-MAILED | 2022-11-01 | |
STATEMENT OF USE PROCESSING COMPLETE | 2022-10-01 | 66530 |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2022-10-01 | 66530 |
USE AMENDMENT FILED | 2022-09-20 | 66530 |
TEAS STATEMENT OF USE RECEIVED | 2022-09-20 | |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2022-06-28 | |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-05-13 | |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2022-05-13 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-05-13 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-05-13 | |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2022-05-13 | 88888 |
PUBLISHED FOR OPPOSITION | 2022-05-03 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-05-03 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-04-13 | |
ASSIGNED TO EXAMINER | 2022-03-25 | 96807 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-03-25 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-09-19 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2021-09-19 | |
NEW APPLICATION ENTERED IN TRAM | 2021-07-19 | |
NEW APPLICATION ENTERED | 2021-07-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.